0001213900-21-045373.txt : 20210827 0001213900-21-045373.hdr.sgml : 20210827 20210827164216 ACCESSION NUMBER: 0001213900-21-045373 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210825 FILED AS OF DATE: 20210827 DATE AS OF CHANGE: 20210827 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tesi Raymond Joseph CENTRAL INDEX KEY: 0001767280 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38793 FILM NUMBER: 211219641 MAIL ADDRESS: STREET 1: 476 MASSACHUSETTS AVE, UNIT 2 CITY: BOSTON STATE: MA ZIP: 02118 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inmune Bio, Inc. CENTRAL INDEX KEY: 0001711754 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 475205835 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1200 PROSPECT STREET STREET 2: SUITE 525 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 8589643720 MAIL ADDRESS: STREET 1: 1200 PROSPECT STREET STREET 2: SUITE 525 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 ownership.xml X0306 4 2021-08-25 0 0001711754 Inmune Bio, Inc. INMB 0001767280 Tesi Raymond Joseph C/O INMUNE BIO INC. 980 NORTH FEDERAL HIGHWAY, SUITE 110 BOCA RATON, FL 33432 1 1 1 0 President and CEO Common Stock 2021-08-25 2021-08-25 4 M 0 30000 3.91 A 1524433 D Employee Stock Option (right to buy) 3.91 2021-08-25 4 M 0 30000 0 D 2029-11-24 Common Stock 30000 270000 D These options were exercised in a cash transaction by the Reporting Person under Rule 16(b)(3). The options were granted to the Reporting Person under the Company's 2019 Stock Incentive Plan. /s/ Raymond Joseph Tesi 2021-08-26